Biotech & MedTech
-
Valeo Pharma revenues jump on increased market share from growing drug portfolio
Valeo Pharma Inc. (TSX: VPH | OTCQB: VPHIF) is a Canadian pharmaceutical company that is seeing significant success…
-
David Regan of Sona Nanotech talks about developments in its unique gold nanorod technology
In this InvestorIntel interview with host Tracy Weslosky, Sona Nanotech Inc.’s (CSE: SONA | OTCQB: SNANF) CEO David…
-
Addiction may have met its match in Awakn Life Sciences therapeutics
Addiction is one of the biggest unmet medical needs globally with substance and behavioral addictions affecting a significant…
-
Greg Fenton of Zentek discusses recent news including a NASDAQ listing and a distribution agreement
In this InvestorIntel interview with host Tracy Weslosky, Zentek Ltd. (NASDAQ: ZTEK | TSXV: ZEN) CEO and Director…
-
Thomas Smeenk of Hemostemix talks about market reaction to successful litigation settlement
In this InvestorIntel interview with host Stephen Lautens, Hemostemix Inc.’s (TSXV: HEM | OTCQB: HMTXF) Co-Founder, President and…
-
Nanotechnology value hunters look at Sixth Wave Innovations
After the last few days and weeks, it seems almost pointless talking about any company that is publicly…
-
Anthony Tennyson of Awakn Life Sciences talks about their portfolio of revolutionary therapeutics and clinics to treat addiction
In this InvestorIntel interview with host Tracy Weslosky, Awakn Life Sciences Corp.’s (NEO: AWKN | OTCQB: AWKNF) Co-Founder &…